Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - DEFERRED INCOME TAX
Deferred Income Tax TRVI - Trevi Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR